Efficacy and Safety of Afatinib Plus Bevacizumab as First‐Line Treatment for Advanced NSCLC Patients With Epidermal Growth Factor Receptor (EGFR) Mutations: A Multicenter, Phase II... by Huiyang Shi, Miaohan Wang, Junling Li, Shi Jin, Minglei Zhuo, Jun Zhao, Hongxia Zhang, Meng Yang, Qingfang Shi, Haifeng Qin, Guilan Dong, Dongmei Lan, Zhong Dai, Yu Feng, Haohua Zhu, Jingyu Lu, Kai Zhu, Yuankai Shi, Xingsheng Hu

Get full text